One-year follow-up of immunocompetent male patients treated with miltefosine for primary visceral leishmaniasis in Bihar, India

Clin Infect Dis. 2013 Nov;57(9):1363-4. doi: 10.1093/cid/cit508. Epub 2013 Aug 13.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antiprotozoal Agents / therapeutic use*
  • Child
  • Follow-Up Studies
  • Humans
  • India
  • Leishmaniasis, Visceral / drug therapy*
  • Male
  • Phosphorylcholine / analogs & derivatives*
  • Phosphorylcholine / therapeutic use
  • Recurrence
  • Treatment Outcome

Substances

  • Antiprotozoal Agents
  • Phosphorylcholine
  • miltefosine